Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing-remitting multiple sclerosis. (Q37979498)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing-remitting multiple sclerosis. |
scientific article |
Statements
Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing-remitting multiple sclerosis (English)
Roland Martin
1 reference